Company: BIAF
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001641172-25-024172
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01 Entry into a Material Definitive Agreement

Private
Placement Transaction

On
August 13, 2025, bioAffinity Technologies, Inc. (the “ Company”) entered into a securities purchase agreement (the “ Purchase
Agreement”) with certain institutional and accredited investors (“the “ Purchasers”), pursuant to which the Company
agreed to issue and sell, in a private placement (the “ Private Placement”), (i) 990 shares of the Company’s newly designated
Series B Convertible Preferred Stock, with a par value $0.001 per share and stated value (the “ Stated Value”) of $1,000 per
share (the “ Series B Preferred Stock”) initially convertible into 4,304,343 shares (the “ Conversion Shares”)
of the Company’s Common Stock, par value $0.007 per share (the “ Common Stock”) at an initial conversion price of $0.23
per share and (ii) warrants (the “ Warrants”) to purchase up to 6,714,780 shares of the Company’s Common Stock at an
exercise price of $0.352 per share of Common Stock.

In
connection with the Private Placement, the Company entered into a registration rights agreement (the “ Registration Rights Agreement”),
dated as of August 13, 2025, with each of the Purchasers, pursuant to which the Company agreed to prepare and file a registration statement
with the Securities and Exchange Commission (the “ SEC”) registering the resale of the shares of Common Stock underlying the
Series B Preferred Stock (the “ Conversion Shares”) and Warrants no later than 15 days after the date of the Registration
Rights Agreement, and to use reasonable best efforts to have the registration statement declared effective as promptly as practical thereafter,
and in any event no later than 60 days following the date of the Registration Rights Agreement (or 90 days following the closing date
in the event of a “full review” by the SEC).

The
closing of the Private Placement took place on August 14, 2025. The gross proceeds to the Company from the Private Placement are expected
to be approximately $1.2 million, before deducting placement agent fees and expenses and estimated offering expenses payable by the Company.
The Company intends to use the net proceeds received from the Private Placement for working capital and general corporate purposes.

WallachBeth
Capital LLC (“ WallachBeth”) served as the Company’s exclusive placement agent in connection with the Private Placement